The AmerisourceBergen Corporation has purchased Innomar Strategies Inc, a Canadian specialty pharmaceutical services company, for approximately $15 million CDN ($13.8 million USD) in cash, subject to a working capital adjustment.

"With Innomar Strategies and our current AmerisourceBergen Specialty Group, Canada, we believe AmerisourceBergen now has the largest and broadest commercialization service offerings to pharmaceutical and biotechnology manufacturers in Canada," said R David Yost, AmerisourceBergen president and chief executive officer. "This acquisition continues our strategy of acquiring companies within our pharmaceutical distribution and related services focus."

Innomar, which is headquartered in the Toronto area with offices in Montreal, has approximately 200 associates. The company provides services within Canada to pharmaceutical and biotechnology companies, including: strategic consulting and access solutions, specialty logistics management, patient assistance and nursing services, and clinical research services.

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets.